Rare diseases
Investigational molecules
Locations
Study on the Effectiveness of Infliximab for Children with Inflammatory Bowel Disease
ItalyStudy on Everolimus and Drug Combination for Children with Relapsed or Refractory Pediatric Cancer
DenmarkStudy on Salbutamol and Ipratropium Bromide for Treating Moderate Asthma Attacks in Children
SpainStudy on Oral Propranolol for Preventing Severe Retinopathy in Premature Infants
GermanyStudy of Early versus Delayed Treatment with Azathioprine or Rituximab in Children with Anti-MOG Antibody Disease
FranceStudy on the Effects of ELGN-2112 (Human Insulin) for Treating Intestinal Malabsorption in Preterm Infants
AustriaStudy on Dexamethasone Phosphate for Reducing Breathing Problems in Children with Upper Airway Obstruction in Intensive Care
FranceStudy on the Safety and Effectiveness of IncobotulinumtoxinA for Treating Limb Spasticity in Children with Cerebral Palsy
ItalyStudy on Early Rituximab Treatment for Children with Nephrotic Syndrome
PolandStudy on the Effects of Filgotinib for Children and Teenagers with Moderate to Severe Ulcerative Colitis
BelgiumStudy of Vedolizumab for Children with Moderate to Severe Ulcerative Colitis or Crohn's Disease
BelgiumStudy on Azithromycin for Treating Hospitalized Children Aged 1-5 with Asthma Symptoms
DenmarkClinical research plays a vital role in developing safe and effective treatments for younger patients. Pediatric clinical trials are trials designed specifically for infants, children, and adolescents. They help researchers understand how new therapies, vaccines, or medical procedures work in younger populations and ensure that treatments are safe and appropriate for their age group.
Children are not simply smaller versions of adults. Their bodies grow and develop, which means medications may work differently than they do in adults. For this reason, therapies must be carefully studied in pediatric populations.
Another important reason for pediatric clinical trials is that some diseases occur primarily or exclusively in children. Certain genetic conditions, developmental disorders, and rare pediatric diseases affect only young patients. Without dedicated research involving children and adolescents, it would be difficult to develop treatments specifically designed for these conditions.
Pediatric research also helps doctors determine:
Participants in pediatric clinical trials may include infants, children, and teenagers depending on the trial design. Each trial has specific eligibility criteria based on age, health condition, and medical history.
Because participants are minors, the process always involves:
This ensures that families fully understand the purpose of the research, the procedures involved, and any potential risks or benefits.
Safety is the highest priority in pediatric clinical trials. These trials follow strict ethical and regulatory standards in Europe and internationally. Research protocols are reviewed by ethics committees and regulatory authorities to ensure that the risks are minimized and justified by the potential benefits of the research.
Children participating in clinical trials are monitored closely by qualified healthcare professionals throughout the entire process. Families receive detailed information about trial procedures, medical monitoring, and the right to withdraw from the trial at any time.
Our search platform allows parents and guardians to explore pediatric clinical trials available in different regions. Using the search tool, families can find trials based on factors such as age group, medical condition, and location.
Clinical trials for children and adolescents are essential for advancing pediatric medicine. By participating in research, families contribute to the development of safer and more effective treatments for young patients today and in the future.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
